Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes
Open accessThe DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Since the 2007 Diabetes Surgery Summit in Rome, Italy, and the subsequent publishing of the world’s first guidelines for the surgical treatment of type 2 diabetes (T2D), much new evidence regarding the efficacy and safety of metabolic surgery has emerged. Additional observational cohort studies support the superior effects of surgery over medical treatment with respect to glycemic control, weight loss, and even reduction in mortality and microvascular complications associated with T2D. Furthermore, new safety data suggest that the perioperative morbidity and mortality of metabolic surgery (5% and 0.3%, respectively) are now similar to that of common low-risk procedures, such as cholecystectomy and hysterectomy. The largest advance, however, has been the completion of 11 randomized controlled trials from around the globe that compare surgery with medical treatment of T2D. These studies with follow-up duration of 1–5 years involve nearly 800 patients without surgical mortality and with major complication rates of less than 5% and a reoperation rate of 8%. All but 1 of the 11 randomized controlled trials have shown the superiority of surgery over medical management at achieving remission or glycemic improvement. Surgery was also superior to medical treatment with respect to improving cardiovascular risk factors, such as weight loss and dyslipidemia, while reducing medication burden. This new efficacy and safety evidence should help guide physicians across the globe to the appropriate use of surgery as an effective treatment for patients suffering from T2D and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Long-term results of MBS consistently demonstrate safety and efficacy.”
From 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After surgery, the significant improvement of metabolic disease, as well as the decrease in overall mortality, has been reported in multiple studies further supporting the importance of this treatment modality [15–19].”
The cited source says what the claim attributes to it.
In the citing paper
“After surgery, the significant improvement of metabolic disease, as well as the decrease in overall mortality, has been reported in multiple studies further supporting the importance of this treatment modality [15–19].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Self-citationBasevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Self-citationGastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163
Cited by
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867
Eisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., De Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., et al. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.08.013 · Cited by 985
“[15] Schauer PR, Mingrone G, Ikramuddin S, Wolfe B.”
BackgroundKhan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797
“…the potential for remission of CKM conditions (eg, restoration of insulin sensitivity to ideal glycemic status, normalization of blood pressure), 10 even back to stage 0 with targeted preventive interventions (eg, health behavior interventions to promote ideal cardiovascular health [CVH]).”
BackgroundEisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., de Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-022-06332-1 · Cited by 768
Treatment of Obesity: Weight Loss and Bariatric Surgery
Wolfe, B. M., Kvach, E., & Eckel, R. H. (2016) · Circulation Research · doi:10.1161/circresaha.116.307591 · Cited by 648
“It has, therefore, been demonstrated that both weight loss and RYGB contribute to the superior remission of diabetes mellitus after gastric bypass compared with LABG.70 Recurrence of diabetes mellitus after induction of remission may occur in as many as 58% of patients 15 years after bariatric surgery, predominantly i…”
Self-citationGadde (2018) · doi:10.1016/j.jacc.2017.11.011 · Cited by 626
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Capristo, E., Chamseddine, G., Bornstein, S. R., & Rubino, F. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32649-0 · Cited by 577
Self-citationSyn, N. L., Cummings, D. E., Wang, L. Z., Lin, D. J., Zhao, J. J., Loh, M., Koh, Z. J., Chew, C. A., Loo, Y. E., Tai, B. C., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00591-2 · Cited by 521
Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R., & Speier, S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.019 · Cited by 489
“For example, bariatric surgeries in obese T2D patients often lead to improvement in glucose control or even diabetes remission within days or weeks [103].”
BackgroundBariatric surgery and long-term nutritional issues
Lupoli, R., Lembo, E., Saldalamacchia, G., Avola, C. K., Angrisani, L., & Capaldo, B. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i11.464 · Cited by 431
Lingvay, I., Cohen, R. V., Roux, C. W. L., & Sumithran, P. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01210-8 · Cited by 433
Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management
Alkhatib, A., Tsang, C., Tiss, A., Bahorun, T., Arefanian, H., Barake, R., Khadir, A., & Tuomilehto, J. (2017) · Nutrients · doi:10.3390/nu9121310 · Cited by 376
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349
Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes
Courcoulas, A. P., Patti, M. E., Hu, B., Arterburn, D. E., Simonson, D. C., Gourash, W. F., Jakicic, J. M., Vernon, A. H., Beck, G. J., Schauer, P. R., et al. (2024) · JAMA · doi:10.1001/jama.2024.0318 · Cited by 284
Self-citationPareek, M., Schauer, P. R., Kaplan, L. M., Leiter, L. A., Rubino, F., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.014 · Cited by 177
Self-citationLi, H., Liu, F., Lu, J., Shi, J., Guan, J., Yan, F., Li, B., & Huo, G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00512 · Cited by 178
“For some patients with obesity to a certain extent, gastric banding, Roux-en-Y gastric bypass and vertical-sleeve gastrectomy, three types of surgery for obesity, are common treatments (Neylan et al., 2016; Schauer et al., 2016).”
BackgroundMetabolic surgery for the treatment of type 2 diabetes in obese individuals
Cummings, D. E., & Rubino, F. (2018) · Diabetologia · doi:10.1007/s00125-017-4513-y · Cited by 179
“It has become clear that certain operations initially designed to promote weight loss also powerfully improve glucose homeostasis, leading to type 2 diabetes remission in most cases, especially after procedures with intestinal bypass components [5].”
BackgroundResultInfluentialRubino, F., Cohen, R. V., Mingrone, G., le Roux, C. W., Mechanick, J. I., Arterburn, D. E., Vidal, J., Alberti, G., Amiel, S. A., Batterham, R. L., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30157-1 · Cited by 174
Self-citationOf mice and men – environmental temperature, body temperature, and treatment of obesity
Reitman, M. L. (2018) · FEBS Letters · doi:10.1002/1873-3468.13070 · Cited by 173
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s008 · Cited by 149
“Weight loss– induced improvements in glycemia aremost likely to occur early in the natural history of type 2 diabetes when obesity-associated insulin resistance has caused reversible b-cell dysfunction but insulin secretory capacity remains relatively preserved (8,11,19,20).”
BackgroundAron‐Wisnewsky, J., Sokolovska, N., Liu, Y., Comaneshter, D. S., Vinker, S., Pecht, T., Poitou, C., Oppert, J., Bouillot, J., Genser, L., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4371-7 · Cited by 154
Debédat, J., Sokolovska, N., Coupaye, M., Panunzi, S., Chakaroun, R., Genser, L., de Turenne, G., Bouillot, J.-L., Poitou, C., Oppert, J.-M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0567 · Cited by 138
“, BMI$30 kg/m(2) with poor glycemic control) (9,10).”
BackgroundSelf-citationSimonson, D. C., Halperin, F., Foster, K., Vernon, A., & Goldfine, A. B. (2018) · Diabetes Care · doi:10.2337/dc17-0487 · Cited by 136
Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2
Cummings, D. E., & Cohen, R. V. (2016) · Diabetes Care · doi:10.2337/dc16-0350 · Cited by 124
“reported historically among patients with a baseline BMI$35 kg/m(2) (2,3,10).”
BackgroundInfluentialAmerican Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s007 · Cited by 117
“Weight loss–induced improvements in glycemia are most likely to occur early in the natural history of type 2 diabetes when obesity-associated insulin resistance has caused reversible b-cell dysfunction but insulin secretory capacity remains relatively preserved (5,8,10,11).”
BackgroundChaar, M. E., Lundberg, P. W., & Stoltzfus, J. C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.011 · Cited by 120
Khorgami, Z., Shoar, S., Saber, A. A., Howard, C. A., Danaei, G., & Sclabas, G. M. (2019) · Obesity Surgery · doi:10.1007/s11695-018-3552-x · Cited by 100
Pucci, A. B. F., Tymoszuk, U., Cheung, W. H., Makaronidis, J., Scholes, S., Tharakan, G., Elkalaawy, M., Guimarães, M., Nora, M., Hashemi, M., et al. (2017) · Diabetic Medicine · doi:10.1111/dme.13532 · Cited by 106
Schiavon, C. A., Bhatt, D. L., Ikeoka, D., Santucci, E. V., Santos, R. N., Damiani, L. P., Oliveira, J. D., Machado, R. H. V., Halpern, H., Monteiro, F. L. J., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3781 · Cited by 94
Incretins in obesity and diabetes
Chia, C. W., & Egan, J. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14211 · Cited by 93
Gut microbiota and health: connecting actors across the metabolic system
Fava, F., Rizzetto, L., & Tuohy, K. M. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002719 · Cited by 105
Singh, P., Subramanian, A., Adderley, N., Gokhale, K., Singhal, R., Bellary, S., Nirantharakumar, K., & Tahrani, A. A. (2020) · British Journal of Surgery · doi:10.1002/bjs.11433 · Cited by 93
Cardiovascular effects of bariatric surgery
Beamish, A. J., Olbers, T., Kelly, A. S., & Inge, T. H. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.162 · Cited by 84
Ceperuelo‐Mallafré, V., Llauradó, G., Keiran, N., Benaiges, E., Astiarraga, B., Martínez, L., Pellitero, S., González-Clemente, J. M., Rodríguez, A., Fernández‐Real, J. M., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0114 · Cited by 87
“of related comorbidities, such as type 2 diabetes and cardiovascular disease, and reducingmortality (1).”
BackgroundOhkuma, T., Woodward, M., Jun, M., Muntner, P., Hata, J., Colagiuri, S., Harrap, S., Mancia, G., Poulter, N., Williams, B., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09359 · Cited by 76
Should bariatric surgery be performed in adolescents?
Beamish, A. J., & Reinehr, T. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0906 · Cited by 84
Bariatric Surgery and Precision Nutrition
Nicoletti, C., Cortes-Oliveira, C., Pinhel, M., & Nonino, C. (2017) · Nutrients · doi:10.3390/nu9090974 · Cited by 61
Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care
Cefalu, W. T., Rubino, F., & Cummings, D. E. (2016) · Diabetes Care · doi:10.2337/dc16-0686 · Cited by 65
Obesity-Related Epigenetic Changes After Bariatric Surgery
Izquierdo, A. G., & Crujeiras, A. B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00232 · Cited by 69
“That study was performed using peripheral blood obtained from obese T2D patients.”
Influentialvan Raalte, D. H., & Verchere, C. B. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12935 · Cited by 69
“In the study with the longest follow up (5 years), T2D remission rates of 42% (gastric bypass) and 68% (biliopancreatic diversion) were observed.(88) Improved glucose homeostasis following”
BackgroundEpigenetics of Hepatic Insulin Resistance
Maude, H., Sanchez-Cabanillas, C., & Cebola, I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.681356 · Cited by 69
Wölnerhanssen, B. K., Moran, A. W., Burdyga, G., Meyer‐Gerspach, A. C., Peterli, R., Manz, M., Thumshirn, M., Daly, K., Beglinger, C., & Shirazi‐Beechey, S. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08487-9 · Cited by 62
Bariatric Surgery as a Long-Term Treatment for Type 2 Diabetes/Metabolic Syndrome
Hanipah, Z. N., & Schauer, P. R. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-053117-123246 · Cited by 58
Self-citationLong-Term Improvement of Chronic Low-Grade Inflammation After Bariatric Surgery
Lautenbach, A., Stoll, F., Mann, O., Busch, P., Huber, T. B., Kielstein, H., Bähr, I., & Aberle, J. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05315-y · Cited by 68
“Data from 11 randomized controlled trials investigating clinical outcomes of metabolic surgery were not powered sufficiently to detect differences in micro- or macrovascular events, especially at relatively short follow-up [24].”
MethodMetabolic Surgery for Hypertension in Patients With Obesity
Pareek, M., Bhatt, D. L., Schiavon, C. A., & Schauer, P. R. (2019) · Circulation Research · doi:10.1161/circresaha.118.313320 · Cited by 64
Self-citationBariatric surgery and obesity: influence on the incretins
Laferrère, B. (2016) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2016.8 · Cited by 57
Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass
Laferrère, B., & Pattou, F. N. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00530 · Cited by 67
“Both observational studies (14) and randomized controlled trials (RCTs) (15) show rates”
BackgroundSchauer, P. R., Hanipah, Z. N., & Rubino, F. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s1.06 · Cited by 56
Self-citationBariatric Surgery in Patients with Cirrhosis and Portal Hypertension
Hanipah, Z. N., Punchai, S., McCullough, A. J., Dasarathy, S., Brethauer, S. A., Aminian, A., & Schauer, P. R. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3372-z · Cited by 52
Self-citationMonnier, L., Schlienger, J.-L., Colette, C., & Bonnet, F. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.09.002 · Cited by 47
Singh, P., Adderley, N. J., Hazlehurst, J., Price, M. J., Tahrani, A. A., Nirantharakumar, K., & Bellary, S. (2021) · Diabetes Care · doi:10.2337/dc21-0166 · Cited by 50
Basal Glucose Can Be Controlled, but the Prandial Problem Persists—It’s the Next Target!
Riddle, M. C. (2017) · Diabetes Care · doi:10.2337/dc16-2380 · Cited by 39
“be cured by this approach, but very impressiveweight loss and improvement of prandial and overall glycemic control are common (40).”
BackgroundImpact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Debédat, J., Amouyal, C., Aron‐Wisnewsky, J., & Clément, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00738-3 · Cited by 48
The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
Jiang, Y., Shui, J., Zhang, B., Chin, J.-W., & Yue, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585487 · Cited by 48
“According to clinical observations, weight loss-induced improvements in glycemia are most likely to occur early in the natural history of T2DM, when obesity-associated IR has caused reversible ß-cell dysfunction, but insulin secretory capacity remains relatively preserved (Schauer et al., 2016; Steven et al., 2016).”
BackgroundMetabolic and Bariatric Surgery for Obesity
Vidal, J., Corcelles, R., Jiménez, A., Flores, L., & Lacy, A. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.051 · Cited by 45
A Comprehensive Review on Bariatric Endoscopy: Where We Are Now and Where We Are Going
Mauro, A., Lusetti, F., Scalvini, D., Bardone, M., Grazia, F. D., Mazza, S., Pozzi, L., Ravetta, V., Rovedatti, L., Sgarlata, C., et al. (2023) · Medicina · doi:10.3390/medicina59030636 · Cited by 44
“Different from medical and dietary approaches, bariatric surgery allows significant results in terms of weight loss, up to 25–30% from basal weight, even during the long-term period [7,8].”
BackgroundReoperative bariatric surgery for treatment of type 2 diabetes mellitus
Yan, J., COHEN, R. V., & Aminian, A. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.04.019 · Cited by 38
Skogar, M. L., & Sundbom, M. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.03.019 · Cited by 41
de Oliveira, V. L. P., Martins, G. P., Mottin, C. C., Rizzolli, J., & Friedman, R. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2830-3 · Cited by 39
Guraya, S. Y., & Strate, T. G. (2019) · International Journal of Surgery · doi:10.1016/j.ijsu.2019.08.010 · Cited by 38
Serum levels of osteopontin predict diabetes remission after bariatric surgery
Carbone, F., Adami, G. F., Liberale, L., Bonaventura, A., Bertolotto, M. B., Andraghetti, G., Scopinaro, N., Camerini, G. B., Papadia, F. S., Cordera, R., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.09.007 · Cited by 33
Dietary Habits, Obesity, and Bariatric Surgery: A Review of Impact and Interventions
Maxim, M., Soroceanu, R. P., Vlăsceanu, V. I., Platon, R., Toader, M. P., Miler, A. A., Onofriescu, A., Abdulan, I. M., Ciuntu, B. M., Bălan, G. G., et al. (2025) · Nutrients · doi:10.3390/nu17030474 · Cited by 44
“The multifactorial etiology of weight regain includes disordered eating behaviors (e.g., loss of control over eating, snacking, emotional eating) [73], psychological factors (e.g., depression, anxiety), anatomical complications, sedentary lifestyles, genetic predispositions [74], and physiological…”
Surgical Treatment of Obesity and Diabetes
Hanipah, Z. N., & Schauer, P. R. (2017) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2016.12.005 · Cited by 37
Self-citationNosso, G., Lupoli, R., Saldalamacchia, G., Griffo, E., Cotugno, M., Costabile, G., Riccardi, G., & Capaldo, B. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.07.004 · Cited by 33
Wu, H., Zhou, Y., Lai, X., Ma, B., Ding, L., Zhu, X., Chen, Z., & Liu, Z. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02932-0 · Cited by 37
“…0–3 is significant for mitigating the disease burden of CKM. Critically, CKM staging is bidirectional, indicating that disease remission (including potential regression to stage 0) may be achieved through targeted preventive interventions [10–12], thus reinforcing confidence in CKM prevention.”
Bakbak, E., Terenzi, D. C., Trac, J. Z., Teoh, H., Quan, A., Glazer, S. A., Rotstein, O. D., Al-Omran, M. A., Verma, S., & Hess, D. A. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09669-7 · Cited by 32
Obesidad y diabetes mellitus tipo 2: también unidas en opciones terapéuticas
Rubio-Almanza, M., Cámara-Gómez, R., & Merino-Torres, J. F. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.08.003 · Cited by 46
Obesity and type 2 diabetes: Also linked in therapeutic options
Rubio-Almanza, M., Cámara-Gómez, R., & Merino-Torres, J. F. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.11.006 · Cited by 34
Casajoana, A., Guerrero‐Pérez, F., de Gordejuela, A. G. R., Admella, V., Sorribas, M., Vidal‐Alabró, A., Virgili, N. M., Urdiales, R. L., Montserrat, M., Pérez-Maraver, M., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05192-x · Cited by 41
Singh, P., Adderley, N. J., Subramanian, A., Gokhale, K. M., Singhal, R., Toulis, K. A., Bellary, S., Nirantharakumar, K., & Tahrani, A. A. (2020) · Diabetes Care · doi:10.2337/dc20-0571 · Cited by 35
“Amongst the several interventions for the treatment of obesity, bariatric surgery (BS) provides the most significant and sustainable weight loss and has a favourable impact on glycaemic control and other vascular risk factors (17-19).”
BackgroundYang, Y., Miao, C., Wang, Y., He, J., & Bo, Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3830 · Cited by 31
“In a meta ‐ analysis of 38 RCTs, short ‐ term all ‐ cause mortality in all patients who received metabolic surgery was 0.18% (95% CI, 0.04%–0.38%).”
InfluentialSalinari, S., Mingrone, G., BERTUZZI, A., Previti, E., Capristo, E., & Rubino, F. (2017) · Diabetes · doi:10.2337/db17-0234 · Cited by 29
“, gastric bypass, biliopancreatic diversion [BPD]) can cause durable remission of type 2 diabetes and dramatic improvements of IR (3,4).”
BackgroundSelf-citationDiedisheim, M., Poitou, C., Genser, L., Amouyal, C., Bouillot, J., Ciangura, C., Oppert, J., Clément, K., & Aron‐Wisnewsky, J. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05075-1 · Cited by 28
Residual cardiovascular risk among people with diabetes
Dash, S., & Leiter, L. A. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13646 · Cited by 27
Varban, O. A., Bonham, A. J., Finks, J. F., Telem, D. A., Obeid, N. R., & Ghaferi, A. A. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.027 · Cited by 24
Bariatric Surgery in Patients on Chronic Anticoagulation Therapy
Sharma, G., Hanipah, Z. N., Aminian, A., Punchai, S., Bucak, E., Schauer, P. R., & Brethauer, S. A. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3120-4 · Cited by 23
Self-citationWu, T., Wong, S. K., Law, B. T. T., Grieve, E., Wu, O., Tong, D. K. H., Leung, D. K. W., Lam, C. L. K., & Wong, C. K. H. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3236 · Cited by 23
“Notably, patients in the control group also experienced weight loss over the years, and around 5% of control patients achieved T2DM remission, although their %TWL did not exceed 5% as stated in the previous literature review.(49) This may because most of T2DM patients in Hong Kong were enrolled in the Risk Assessment…”
ResultManagement of Diabetes in Patients Undergoing Bariatric Surgery
Mulla, C. M., Baloch, H. M., & Hafida, S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1242-2 · Cited by 27
Phelan, S. M. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000431 · Cited by 25
Zhong, P., Zeng, H., Huang, M., He, G., & Chen, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.695182 · Cited by 27
“…and moderately improves insulin secretory capacity of pancreatic β-cells and insulin resistance (Steven et al., 2016; Taylor et al., 2019), thereby leading to a significant improvement in glycemic control and even remission of T2D (Schauer et al., 2016; Lean et al., 2018; Lean et al., 2019).”
BackgroundAcute Effects of Sleeve Gastrectomy on Glucose Variability, Glucose Metabolism, and Ghrelin Response
Wang, L., Shi, C., Yan, H., Xia, M., Zhu, X., Sun, X., Yang, X., Jiao, H., Wu, H., Lou, W., et al. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05534-3 · Cited by 24
“Bariatric surgery, primarily designed for the treatment of morbid obesity, has been recently proposed as an effective and safe therapeutic modality against T2DM [2].”
BackgroundMirghani, H. O., & Albalawi, I. A. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01001-4 · Cited by 24
“The term indicates improvement or even remission of metabolic disorders including type 2 diabetes [21].”
BackgroundFan, B., Lim, C. K. P., Poon, E. W. M., Lau, E. S. H., Wu, H., Yang, A., Shi, M., Tam, C. H. T., Wong, S. Y. S., Lee, E. K. P., et al. (2023) · Diabetes Care · doi:10.2337/dc22-2301 · Cited by 27
“function, and improve glycemic durability in patients with T2D (35,36).”
BackgroundEffect of bariatric surgery on circulating FGF‐19: A systematic review and meta‐analysis
Ryan, P. M., Hayward, N. E., Sless, R. T., Garwood, P., & Rahmani, J. (2020) · Obesity Reviews · doi:10.1111/obr.13038 · Cited by 23
“In addition, BS often carry the added benefit of improved glycaemic control, an effect which appears to be somewhat uncoupled from the degree of weight loss, as it often precedes the latter following such procedures.(3,4) However, bariatric”
Backgrounddos Rodrigues, L. S., de Vasconcelos, P. H., & Gomes, D. L. (2020) · Eating and Weight Disorders · doi:10.1007/s40519-020-00973-w · Cited by 17
Glaysher, M. A., Ward, J., Aldhwayan, M., Ruban, A., Prechtl, C. G., Fisk, H. L., Chhina, N., Al‐Najim, W., Smith, C., Klimowska‐Nassar, N., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.026 · Cited by 19
“In addition, one side effect of surgical 144 procedures that aim to reduce nutrient absorption is impaired availability of essential 145 micronutrients [13,14].”
BackgroundTolvanen, L., Christenson, A., Bonn, S. E., Surkan, P. J., & Lagerros, Y. T. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06718-9 · Cited by 26
“Bariatric surgery has been recognized as a safe, evidencebased treatment for obesity, contributing to long-term weight loss and improved health outcomes [1, 2].”
BackgroundStubbs, R. J., Duarte, C., O’Driscoll, R., Turicchi, J., Kwaśnicka, D., Sniehotta, F. F., Marques, M. M., Horgan, G. W., Larsen, S. C., Palmeira, A. L., et al. (2021) · Obesity Facts · doi:10.1159/000513042 · Cited by 20
“Those for bypass (anastomotic strictures, marginal ulcers, bowel obstructions), range between 1 and 5% [6].”
BackgroundInfluentialFaenza, M., Benincasa, G., Docimo, L., Nicoletti, G. F., & Napoli, C. (2021) · Updates in Surgery · doi:10.1007/s13304-021-01162-9 · Cited by 22
Obesity and its management in primary care setting
Ibrahim, M. A., Ba-Essa, E. M., Alvarez, J. A., Baker, J. C., Bruni, V., Cahn, A., Ceriello, A., Cosentino, F., Davies, M. J., Domenico, F. D., et al. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109045 · Cited by 21
Scores for Predicting Diabetes Remission in Bariatric Surgery: a Systematic Review and Meta-analysis
Sesconetto, L. D. A., da Silva, R. B. R., Galletti, R. P., Agareno, G. A., Colonno, B. B., de Sousa, J. H. B., & Tustumi, F. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06382-5 · Cited by 17
“In this setting, bariatric surgery has proven to improve glycemic control of diabetic patients with obesity and promote weight loss [5].”
BackgroundDistinct B cell profiles characterise healthy weight and obesity pre- and post-bariatric surgery
Šlisere, B., Arisova, M., Aizbalte, O., Salmiņa, M., Zolovs, M., Levenšteins, M., Mukāns, M., Troickis, I., Meija, L., Lejnieks, A., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01344-y · Cited by 18
Obesity therapeutics: The end of the beginning
Gribble, F. M., & O’Rahilly, S. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.012 · Cited by 18
Kim, J. H., Pyo, J., Cho, W. J., & Kim, S. Y. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04257-w · Cited by 15
Laparoscopic loop duodenaljejunal bypass with sleeve gastrectomy in type 2 diabetic patients
Hanipah, Z. N., Hsin, M.-C., Liu, C.-C., & Huang, C. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.01.016 · Cited by 16
Holst, J. J., Madsbad, S., Bojsen-Møller, K. N., Dirksen, C., & Svane, M. S. (2024) · Peptides · doi:10.1016/j.peptides.2024.171199 · Cited by 18
“…cardio-and cerebrovascular insults; amelioration of type 2 diabetes with HbA1c reduction of 22 – 38 mmol/mol vs. 11 – 16 mmol/mol in response to conventional treatment; amelioration of hypertension, dyslipidemia, NAFLD, PCOS, sleep apnoea and osteo-arthritis; and improved quality of life [24,25].”
BackgroundBlood methylation pattern reflects epigenetic remodelling in adipose tissue after bariatric surgery
Müller, L., Hoffmann, A., Bernhart, S. H., Ghosh, A., Zhong, J., Hagemann, T., Sun, W., Dong, H., Noé, F., Wolfrum, C., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105242 · Cited by 17
“7,8 Furthermore, bariatric surgery reduces chronic low-grade in fl ammation, 9,10 the risk of several cancer types, 11 and improves cardiovascular function, 12 but the underlying molecular pathways are not completely understood.”
BackgroundJonsson, I., Bojsen-Møller, K. N., Kristiansen, V. B., Veedfald, S., Albrechtsen, N. J. W., Clausen, T. R., Kuhre, R. E., Rehfeld, J. F., Holst, J. J., Madsbad, S., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.681116 · Cited by 15
Effects of bariatric surgery on retinal microvascular architecture in obese patients
Viljanen, A. P. M., Soinio, M., Cheung, C. Y.-L., Hannukainen, J. C., Karlsson, H. K., Wong, T. Y., Hughes, A. D., Salminen, P. T. P., Nuutila, P., Vesti, E. T., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0242-7 · Cited by 18
Bariatric surgery in patients with pulmonary hypertension
Hanipah, Z. N., Mulcahy, M. J., Sharma, G., Punchai, S., Steckner, K., Dweik, R. A., Aminian, A., Schauer, P. R., & Brethauer, S. A. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.07.015 · Cited by 15
Self-citation
Metadata
- Authors
- Schauer, P. R., Mingrone, G., Ikramuddin, S., & Wolfe, B.
- Affiliations
- Cleveland Clinic (US)
- Catholic University, Rome, Italy
- University of Minnesota (US)
- Oregon Health & Science University (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-05-13
- Volume
- 39
- Issue
- 6
- Pages
- 902-911
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5864131
- OpenAlex
- W2404591441
- Cited by
- 215
- References
- 66
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 14 · 2023: 20 · 2022: 15 · 2021: 25 · 2020: 24 · 2019: 25 · 2018: 29 · 2017: 27 · 2016: 9
- FWCI
- 33.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- metabolic surgery, type 2 diabetes, diabetes remission, glycemic control, weight loss, obesity, perioperative morbidity, surgical safety, cardiovascular risk factors, dyslipidemia, medication burden, randomized controlled trials, surgical versus medical treatment
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Consensus Statements as Topic, Diabetes Mellitus, Type 2, Female, Humans, Obesity, Remission Induction, Risk Factors, Cohort Studies, Weight Loss, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.